Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Imaging oxygenation of human tumours.

Padhani AR, Krohn KA, Lewis JS, Alber M.

Eur Radiol. 2007 Apr;17(4):861-72. Epub 2006 Oct 17. Review.

2.

PET imaging of tumour hypoxia.

Padhani A.

Cancer Imaging. 2006 Oct 31;6:S117-21. Review. Retraction in: Cancer Imaging. 2007;7:1.

3.

Where are we with imaging oxygenation in human tumours?

Padhani AR.

Cancer Imaging. 2005 Nov 28;5:128-30.

4.

Imaging hypoxia in gliomas.

Mendichovszky I, Jackson A.

Br J Radiol. 2011 Dec;84 Spec No 2:S145-58. doi: 10.1259/bjr/82292521. Review.

5.

Dose prescription and optimisation based on tumour hypoxia.

Toma-Daşu I, Daşu A, Brahme A.

Acta Oncol. 2009;48(8):1181-92. doi: 10.3109/02841860903188643.

PMID:
19863227
6.

Radiolabelled agents for PET imaging of tumor hypoxia.

Kurihara H, Honda N, Kono Y, Arai Y.

Curr Med Chem. 2012;19(20):3282-9. Review.

PMID:
22664246
7.

Imaging hypoxia in tumours with advanced MRI.

Price JM, Robinson SP, Koh DM.

Q J Nucl Med Mol Imaging. 2013 Sep;57(3):257-70. Review.

8.

The meaning, measurement and modification of hypoxia in the laboratory and the clinic.

Hammond EM, Asselin MC, Forster D, O'Connor JP, Senra JM, Williams KJ.

Clin Oncol (R Coll Radiol). 2014 May;26(5):277-88. doi: 10.1016/j.clon.2014.02.002. Epub 2014 Mar 3. Review.

9.

Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.

Myerson RJ, Singh AK, Bigott HM, Cha B, Engelbach JA, Kim J, Lamoreaux WT, Moros E, Novak P, Sharp TL, Straube W, Welch MJ, Xu M.

Int J Hyperthermia. 2006 Mar;22(2):93-115.

PMID:
16754595
10.

Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy.

Dalah E, Bradley D, Nisbet A.

Phys Med Biol. 2010 Feb 7;55(3):681-94. doi: 10.1088/0031-9155/55/3/009. Epub 2010 Jan 13.

PMID:
20071761
11.

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.

Bourgeois M, Rajerison H, Guerard F, Mougin-Degraef M, Barbet J, Michel N, Cherel M, Faivre-Chauvet A.

Nucl Med Rev Cent East Eur. 2011;14(2):90-5. Review.

12.

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1171-82.

PMID:
11240261
13.

Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.

Bonnitcha PD, Bayly SR, Theobald MB, Betts HM, Lewis JS, Dilworth JR.

J Inorg Biochem. 2010 Feb;104(2):126-35. doi: 10.1016/j.jinorgbio.2009.10.009. Epub 2009 Oct 24.

14.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.

O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502.

PMID:
15817355
15.

Rapid dual-tracer PTSM+ATSM PET imaging of tumour blood flow and hypoxia: a simulation study.

Rust TC, Kadrmas DJ.

Phys Med Biol. 2006 Jan 7;51(1):61-75. Epub 2005 Dec 15.

PMID:
16357431
16.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
17.

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M.

J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033. Epub 2013 Apr 14.

18.

The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.

Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, Carson J, Sowers AL, English S, Green MV, Bacharach SL, Eckelman WC, Mitchell JB.

Int J Oncol. 2007 Apr;30(4):873-81.

PMID:
17332926
19.

Tumoral hypoxia in osteosarcoma in rats: preliminary study of blood oxygenation level-dependent functional MRI and 18F-misonidazole PET/CT with diffusion-weighted MRI correlation.

Dallaudiere B, Hummel V, Hess A, Lincot J, Preux PM, Maubon A, Monteil J.

AJR Am J Roentgenol. 2013 Feb;200(2):W187-92. doi: 10.2214/AJR.12.8969.

PMID:
23345383
20.

Imaging tumour hypoxia with positron emission tomography.

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, Domarkas J, Lord S, Baldry C, Gilbert FJ.

Br J Cancer. 2015 Jan 20;112(2):238-50. doi: 10.1038/bjc.2014.610. Epub 2014 Dec 16. Review.

Supplemental Content

Support Center